Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Netflix Crashes As 'Stranger Things 4' Volume 2 Goes Live: Was Vecna To Blame?

Talk about bad timing: Netflix (NASDAQ: NFLX) crashed earlier this morning shortly after the final two episodes of its hit series "Stranger Things 4" went live.

What 6 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical

What 6 Analyst Ratings Have To Say About Ultragenyx Pharmaceutical

Analysts have provided the following ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) within the last quarter:

Here's How Much $100 Invested In O'Reilly Automotive 15 Years Ago Would Be Worth Today

Here's How Much $100 Invested In O'Reilly Automotive 15 Years Ago Would Be Worth Today

O'Reilly Automotive (NASDAQ:ORLY) has outperformed the market over the past 15 years by 14.76% on an annualized basis producing an average annual return of 20.97%. Currently, O'Reilly Automotive has a market capitalization of $41.50 billion.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Where Pinnacle Finl Partners Stands With Analysts

Analysts have provided the following ratings for Pinnacle Finl Partners (NASDAQ:PNFP) within the last quarter:

Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022

Nemaura Medical's Return On Capital Employed Insights

Nemaura Medical (NASDAQ:NMRD) brought in sales totaling $320.28 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 5.41%, resulting in a loss of $3.62 million.

Simply Good Foods's Return On Capital Employed Overview

According to Benzinga Pro, during Q3, Simply Good Foods (NASDAQ:SMPL) earned $38.83 million, a 110.36% increase from the preceding quarter. Simply Good Foods also posted a total of $316.53 million in sales, a 6.68% increase since Q2.

inkl

Read news from The Economist, FT, and more,
with one subscription

Celldex's Barzolvolimab Shows Rapid, Durable Responses In Early Urticaria Study

Celldex's Barzolvolimab Shows Rapid, Durable Responses In Early Urticaria Study

Celldex Therapeutics Inc (NASDAQ:CLDX) announced interim data from Phase 1b trial of barzolvolimab in chronic spontaneous urticaria (CSU) refractory to antihistamines. CSU is characterized by the occurrence of hives or weals for six weeks or longer without identifiable specific triggers or causes. Data show that multiple doses of barzolvolimab resulted in dose-dependent decreases…

Why U.S. Stocks Are Trading Higher, Manufacturing Report And More

Why U.S. Stocks Are Trading Higher, Manufacturing Report And More

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

Here's Why VerifyMe Shares Are Trading Higher Today

Here's Why VerifyMe Shares Are Trading Higher Today

VerifyMe, Inc (NASDAQ:VRME) elected not to extend the period for a special purpose acquisition company (SPAC) merger with G3 VRM Acquisition Corp (NASDAQ:GGGVU). VerifyMe's board determined that it was not in its best interests to allocate additional financial capital at this time for the SPAC to consummate a business combination. Instead, it will focus on…

What 8 Analyst Ratings Have To Say About Paramount Global

What 8 Analyst Ratings Have To Say About Paramount Global

Analysts have provided the following ratings for Paramount Global (NASDAQ:PARA) within the last quarter:

$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying

$1 Million Bet On CalAmp? 4 Penny Stocks Insiders are Buying

U.S. stocks opened slightly lower on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Analyst Ratings for Wingstop

Analyst Ratings for Wingstop

Analysts have provided the following ratings for Wingstop (NASDAQ:WING) within the last quarter:

Expert Ratings for Live Oak Bancshares

Expert Ratings for Live Oak Bancshares

Analysts have provided the following ratings for Live Oak Bancshares (NASDAQ:LOB) within the last quarter:

Get all your
news in one place.

100’s of premium titles.
One news app.

7 Analysts Have This to Say About Iovance Biotherapeutics

Iovance Biotherapeutics (NASDAQ:IOVA) has observed the following analyst ratings within the last quarter:

China Cracks Down On Counterfeit Investment Platforms

China's cyberspace regulator has cracked down on counterfeit investment platforms, Reuters reports.

Here's Why Micron, TSMC, AMD, Nvidia, Qualcomm And Other Chipmakers Are Trading Lower Premarket

Chipmaking stocks are bleeding post Micron Technology, Inc's (NASDAQ: MU)

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact

Here's a roundup of top developments in the biotech space over the last 24 hours:

Get all your
news in one place.

100’s of premium titles.
One news app.

Netflix To $210? Here's The Biggest Price Target Changes For Friday

Piper Sandler cut The Goldman Sachs Group, Inc. (NYSE: GS) price target from $430 to $410. Goldman Sachs shares fell 0.1% to $296.79 in pre-market trading.

Canopy Growth Enters Into Additional Exchanges With Holders Of Notes

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) has entered into an additional privately negotiated exchange agreement with a holder of the company's outstanding 4.25% unsecured senior notes due 2023, to acquire approximately CA$7.25 million ($5.6 million) aggregate p

Benzinga Before The Bell: Kohl's Deal Talks Cancellation, Tesla's Racial Discrimination Lawsuit, Nio's Strong June Deliveries And Other Top Financial Stories Friday, July 1

CNBC Why Kohl’s Shares Are Plunging Today

Endo Posts Disappointing Data From Frozen Shoulder Trial

Endo International plc (NASDAQ:ENDP) has announced topline results from its Phase 2 study of collagenase clostridium histolyticum (CCH) in participants with adhesive capsulitis (AC) of the shoulder (frozen shoulder). While participants receiving up to three doses of CCH showed some improvement in the change from baseline in the shoulder pathology composite score, the…

Amazon, AT&T, Disney Paying For Abortion Travel Costs Had Also Contributed To Anti-Abortion Campaigns: Bloomberg

Amazon.com Inc (NASDAQ: AMZN), AT&T Inc (NYSE: T), and Walt Disney Company (NYSE: DIS), pledging to pay for e

Electronic Arts And 2 Other Stocks Insiders Are Selling

US crude oil futures traded higher this morning on Friday. Investors, meanwhile, focused on some notable insider trades.

Tesla Hit By New Class-Action Lawsuit Claiming Racial Discrimination: Report

Fifteen black employees of Tesla Inc (NASDAQ: TSLA), including former or current, have filed a lawsuit alleging racial abuse and harassment at the company's factories,

1 … 334 335 336 337

People

Mark Zuckerberg

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

340,723 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play